Skip to
  1. Homepage
  2. Rare diseases
  3. Search
Simple search

Simple search

*
(*) mandatory field





 

Other search option(s)

Noonan syndrome

Orpha number ORPHA648
Synonym(s) -
Prevalence Unknown
Inheritance Autosomal dominant
Age of onset Neonatal
ICD-10
  • Q87.1
ICD-O -
OMIM
UMLS
  • C0028326
MeSH
  • D009634
MedDRA
  • 10029748

Summary

Noonan Syndrome (NS) is characterised by short stature, typical facial dysmorphism and congenital heart defects. The incidence of NS is estimated to be between 1:1000 and 1:2500 live births. The main facial features of NS are hypertelorism with down-slanting palpebral fissures, ptosis and low-set posteriorly rotated ears with a thickened helix. The cardiovascular defects most commonly associated with this condition are pulmonary stenosis and hypertrophic cardiomyopathy. Other associated features are webbed neck, chest deformity, mild intellectual deficit, cryptorchidism, poor feeding in infancy, bleeding tendency and lymphatic dysplasia. The syndrome is transmitted as an autosomal dominant trait. In approximately 50% of cases, the disease is caused by missense mutations in the PTPN11 gene (12q24.1), resulting in a gain of function of the non-receptor protein tyrosine phosphatase SHP-2 protein. Recently, mutations in other genes from the RAS MAPK pathway (KRAS, SOS1, and RAF1) have been identified in a small portion of patients with NS. Mutation analysis can be carried out on blood samples and should be recommended for any subject with a suspected diagnosis of NS. However, the diagnosis cannot be excluded on a molecular basis, as the sensitivity of combined screening of all known genes allows confirmation in less than 75% of patients. The differential diagnosis should include Turner syndrome, cardiofaciocutaneous syndrome, Costello syndrome, neurofibromatosis type 1 (NF1) and LEOPARD syndrome (see these terms). Prenatal DNA testing can be carried out on chorionic villus and amniotic fluid samples if the mutation has already been identified in a family member, but the complexity of the analysis makes diagnosis on an index case technically challenging during the short period of time available during pregnancy. Preimplantation genetic diagnosis may also be a possibility. NS should be considered in all foetuses with polyhydramnios, pleural effusions, oedema and increased nuchal fluid with a normal karyotype. Management should address feeding problems in early childhood, and include evaluations of cardiac function and assessments of growth and motor development. Physiotherapy and speech therapy should be offered if indicated. A complete eye examination and hearing evaluation should be performed during the first few years of schooling. Preoperative coagulation studies are indicated. With special care and counselling, the majority of children with NS will grow up and function normally in the adult world. Signs and symptoms lessen with age and most adults with NS do not require special medical care.

Expert reviewer(s)

  • Dr Ineke VAN DER BURGT

(*) Required fields.

Attention: Only comments seeking to improve the quality and accuracy of information on the Orphanet website are accepted. For all other comments, please send your remarks via contact us. Only comments written in English can be processed.


Captcha image

Detailed information

Summary information
Review article
  • EN (2007)
Clinical practice guidelines
  • NL (2010,pdf)
Article for general public
  • FR (2006,pdf)
Clinical genetics review
  • EN (2011)
Get Acrobat Reader
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.